Zdrowie i gospodarka · 29/07/2020
FDA Mandates Electronic Submission of Postmarketing Safety Reports for New Animal Drugs
The US Food and Drug Administration is requiring the electronic submission of postmarketing safety reports for new animal drugs, with an option to request a temporary waiver.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →